A SNAP-Tagged Derivative of HIV-1—A Versatile Tool to Study Virus-Cell Interactions by Eckhardt, Manon et al.
A SNAP-Tagged Derivative of HIV-1—A Versatile Tool to
Study Virus-Cell Interactions
Manon Eckhardt
1, Maria Anders
1, Walter Muranyi
1, Mike Heilemann
2,3, Jacomine Krijnse-Locker
1,4,
Barbara Mu ¨ller
1*
1Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany, 2BIOQUANT Centre, University of Heidelberg, Heidelberg, Germany,
3Biotechnology and Biophysics, Julius-Maximilians-University Wu ¨rzburg, Wu ¨rzburg, Germany, 4Electron Microscopy Core Facility, BIOQUANT, University of Heidelberg,
Heidelberg, Germany
Abstract
Fluorescently labeled human immunodeficiency virus (HIV) derivatives, combined with the use of advanced fluorescence
microscopy techniques, allow the direct visualization of dynamic events and individual steps in the viral life cycle. HIV
proteins tagged with fluorescent proteins (FPs) have been successfully used for live-cell imaging analyses of HIV-cell
interactions. However, FPs display limitations with respect to their physicochemical properties, and their maturation
kinetics. Furthermore, several independent FP-tagged constructs have to be cloned and characterized in order to obtain
spectral variations suitable for multi-color imaging setups. In contrast, the so-called SNAP-tag represents a genetically
encoded non-fluorescent tag which mediates specific covalent coupling to fluorescent substrate molecules in a self-labeling
reaction. Fusion of the SNAP-tag to the protein of interest allows specific labeling of the fusion protein with a variety of
synthetic dyes, thereby offering enhanced flexibility for fluorescence imaging approaches. Here we describe the
construction and characterization of the HIV derivative HIV
SNAP, which carries the SNAP-tag as an additional domain within
the viral structural polyprotein Gag. Introduction of the tag close to the C-terminus of the matrix domain of Gag did not
interfere with particle assembly, release or proteolytic virus maturation. The modified virions were infectious and could be
propagated in tissue culture, albeit with reduced replication capacity. Insertion of the SNAP domain within Gag allowed
specific staining of the viral polyprotein in the context of virus producing cells using a SNAP reactive dye as well as the
visualization of individual virions and viral budding sites by stochastic optical reconstruction microscopy. Thus, HIV
SNAP
represents a versatile tool which expands the possibilities for the analysis of HIV-cell interactions using live cell imaging and
sub-diffraction fluorescence microscopy.
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Introduction
The labeling of individual viral proteins by fusion to fluorescent
molecules in conjunction with advanced fluorescence imaging
techniques has greatly expanded the possibilities to investigate
virus-cell interactions. This includes live-cell imaging approaches
to study the dynamics of intracellular events as well as super-
resolution fluorescence microscopy methods surmounting the
diffraction barrier of light microscopy, which allow the analysis
of fluorescently labeled structures at a resolution down to ,20 nm
(for review see [1,2]). Human immunodeficiency virus (HIV)
derivatives labeled by fusion of fluorescent proteins (FPs) to the
structural polyprotein Gag, the accessory protein Vpr or the viral
integrase, respectively, have been successfully employed to analyze
cell entry as well as particle assembly of HIV by live cell
fluorescence microscopy (e.g. [3–11], reviewed in [2,12]). Sub-
diffraction microscopy has been employed in proof of principle
studies to display the distribution and mobility of HIV-1 Gag
molecules at the plasma membrane of virus producing cells
[13,14]. While FPs have become invaluable tools in cell biology
and virology, some of their properties present disadvantages which
limit their usefulness in live-cell microscopy: (i) FPs are inferior to
many modern synthetic fluorophores with respect to quantum
yield and photostability, which restricts time resolution and the
duration of observation in live-cell experiments. (ii) Although a
continuously increasing range of FPs with different spectral
properties is available [15], the color range is limited, in particular
in the blue and far-red range. Only few FPs display the
photophysical properties rendering them suitable for sub-diffrac-
tion microscopy methods. (iii) The fluorophores of FP display
relatively slow maturation kinetics [16]; consequently, newly
expressed FP molecules are initially undetectable by fluorescence
microscopy, which limits their use in pulse-chase experiments. (iv)
Some FPs are obligatory multimers, which may affect the
functionality of the cellular fusion partner. (v) Finally, experimen-
tal setups in cell biology often involve multi-color approaches using
several differentially labeled proteins. In the case of FP fusion
proteins, individual expression constructs have to be cloned and
characterized in order to obtain different spectral variants of a
protein of interest. Genetically encoded non-fluorescent labels
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offer a greater flexibility in the choice of label. A well-known
example of this type of motifs is the six to twelve amino acid long
tetracysteine (TC)-tag [17], which is attractive due to its small size.
The TC-tag has been employed for the generation of tagged HIV
derivatives [18–20]; however, disadvantages of this system include
a high degree of intracellular background staining [21,22], the
dependency of staining from the redox state of the tag [17] and a
very limited selection of compatible fluorescent dyes. We therefore
decided to explore the use of the so-called SNAP-tag for labeling of
HIV. The SNAP-tag is a genetically encoded label with a slightly
lower molecular mass than FPs (,20 kDa), which is derived from
of the mammalian DNA repair protein O
6-alkylguanin-DNA-
alkyltransferase. It stably transfers the benzyl moiety of O
6-
benzylguanine (BG) substrates to its active site [23] and thereby
performs a self-labeling reaction when fluorescently labeled
derivatives of BG are offered as substrate [24]. Analogous to FP
encoding sequences, the SNAP-tag coding sequence can be
genetically fused to the coding sequence of any protein of interest.
The resulting fusion protein is non-fluorescent but can be labeled
upon addition of the substrate of choice. Available BG coupled
dyes represent a wide variety of synthetic fluorophores with good
quantum yield and photostability. As the reactivity of the SNAP-
tag is largely independent of the nature of the attached fluorescent
probe [24], any available synthetic dye coupled to BG can in
principle be used in this setting. Here, we describe the generation
and characterization of an HIV derivative which carries a SNAP-
tag within the main structural polyprotein Gag. HIV Gag is
necessary and sufficient for formation and release of virus like
particles from expressing cells [25]. During the HIV assembly
process, Gag orchestrates the incorporation of other virion
components and interacts with cellular factors required for particle
release. The fate of Gag during the replication cycle of HIV has
been studied by a variety of methods (for review see e.g. [26–28]).
However, further elucidation especially of the dynamic interac-
tions with host cellular proteins will be of major interest. The
SNAP-tagged HIV derivative (HIV
SNAP) established in this study
was functional with respect to virus-cell fusion and particle
assembly and allowed virus replication in tissue culture. Gag.S-
NAP could be specifically stained in the viral and cellular context.
HIV
SNAP thus represents a versatile tool to study HIV-cell
interactions.
Results and Discussion
For introduction of the SNAP-tag into the HIV structural
polyprotein Gag we made use of the fact that Gag is a modular
protein, consisting of individually folded subdomains separated by
flexible linker regions [29]. Proteolytical processing by the viral
protease (PR) at specific sites within these linker regions triggers
morphologic rearrangements of the mature Gag subunits matrix
(MA), capsid (CA), nucleocapsid (NC) and p6 within the virion,
which are essential for virion infectivity. Cryo electron microscopy
had shown that within the immature virion, Gag molecules are
arranged in a parallel manner underneath the viral membrane,
and the region separating the globular MA and CA domains of
Gag forms a layer of low protein density [30]. We have previously
demonstrated that foreign amino acid sequences can be inserted
within this region without affecting Gag expression, assembly or
proteolytic maturation, and that small insertions are tolerated
without affecting virus replication in tissue culture [31]; this has
been exploited for the construction of various modified HIV
derivatives by us and others [4,19,31–33]. Based on this, we
cloned the SNAP-tag coding sequence between the codons for
amino acids 128 and 129 of MA as outlined in Figure 1 A. Four C-
terminal residues of MA were retained C-terminally of SNAP in
order to allow efficient processing downstream of MA.SNAP by
HIV PR (HIV
SNAP, Figure 1 A). The SNAP-tagged derivative was
generated both in the context of an infectious HIV-1NL4-3 based
proviral plasmid (yielding pNLC
SNAP), as well as in the context of
the non-replication competent derivative pCHIV [4], which lacks
the viral long terminal repeat regions but encodes all HIV proteins
except for Nef (pCHIV
SNAP). In addition we constructed an HIV-
1NL4-3 derivative carrying the SNAP-tag between MA and CA
flanked by two PR cleavage sites (pNLC
iSNAP; HIV
iSNAP, Figure 1
A). In the case of eGFP labeled derivatives, the analogous
construct pNLC
eGFP did not display robust replication in tissue
culture, while the introduction of an additional PR cleavage site
upstream of the eGFP domain was reported to display nearly wild-
type (wt) replication kinetics at least in MT-4 T-cells [33]. Virus
particles prepared by ultracentrifugation from the tissue culture
supernatant of 293T cells transfected with pNLC4-3, pNLC
SNAP
and pNLC
iSNAP, respectively, were analyzed by immunoblot for
HIV protein composition, proteolytic processing of polyproteins,
as well as for the presence of SNAP-tag fusion proteins. Particles
displayed the expected viral protein composition and the modified
Gag.SNAP polyprotein was efficiently processed during particle
maturation (Figure 1 B and data not shown). The fusion protein
MA.SNAP (,37 kDa), reactive to immunostaining with antiserum
raised against HIV-1 MA as well as with anti-SNAP antiserum,
was shown to be present in HIV
SNAP particles, whereas two
separate bands, corresponding to MA (17 kDa) and SNAP
(20 kDa), were detected in immunoblots of HIV
iSNAP samples.
Electron micrographs of cells transfected with either wt (Figure 1
C) or SNAP-tagged proviral plasmids (Figure 1 D) showed viral
budding profiles as well as immature and mature virions. Cells
transfected with the SNAP-tagged derivative displayed a higher
number of early budding structures; similar results had been
obtained for an eGFP-tagged HIV derivative [31]. Since only
moderately reduced amounts of virus particles were pelleted from
the supernatants of HIV wt and pCHIV
SNAP transfected cells
harvested at 40 h post transfection (see Figure 2 A, black bars), this
phenotype may be explained by delayed budding kinetics,
resulting in increased numbers of budding structures detected in
the steady state represented in still images. Mature HIV
SNAP
particles were found to display wt morphology (Figure 1 D).
We then characterized the functional properties of the modified
virus. The FP labeled derivative HIV
eGFP had been shown to be
infectious in tissue culture, but its infectivity was significantly
reduced compared to wt HIV [31] and did not sustain multiple
replication rounds in tissue culture. Co-transfection of cells with an
equimolar mixture of pNLC
eGFP and wt pNLC4-3 results in the
production of mixed particles displaying wt single-round infectivity
[31]. The introduction of other foreign sequences between the MA
and CA domains yielded HIV derivatives with varying levels of
infectivity, ranging from wt infectivity to a complete lack of
particle production ([18,19,31,32] and unpublished observations).
Despite a trend towards smaller insertions generally being more
favorable, we did not observe a direct correlation between the
molecular mass of the inserted domain and the infectivity of the
modified virus in our own studies. We compared HIV
SNAP and
HIV
iSNAP to the wt virus, as well as to mixed particles carrying
approximately equimolar amounts of Gag and Gag.SNAP,
respectively, with respect to the efficiency of individual replication
steps (Figure 2 A). In order to determine the efficiency of
cytoplasmatic entry, we made use of the so-called beta-lactamase
virion fusion assay (BlaM assay) for HIV cell fusion [34]. This
assay relies on reporter virions carrying beta-lactamase (BlaM);
A SNAP-Tagged Derivative of HIV-1
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by loading the target cells with the fluorescent substrate CCF-2,
which changes its fluorescence properties upon BlaM mediated
cleavage. Reporter particles were prepared from the tissue culture
supernatant of 293T cells co-transfected with plasmids pMM310
(coding for Vpr.BlaM) and pCHIV, pCHIV
SNAP, or an equimolar
mixture of both, respectively. Fusogenicity of particles was tested
by incubation of JC53 cells with equal amounts of virus followed
by CCF-2 staining and fluorimetric analysis as described in the
methods section. We found that pCHIV
SNAP derived particles
(HIV
SNAP) displayed comparable fusion efficiency as their
unlabeled counterpart (HIV) or the mixed virions (HIV
SNAP
+HIV), respectively (Figure 2 A, white bars). Virion infectivity was
analyzed by incubating TZM-bl reporter cells with particles
prepared from 293T cells transfected with pNLC4-3, pNLC
SNAP,
a mixture of both plasmids, or pNLC
iSNAP, respectively. Analysis
of HIV induced luciferase reporter activity at 48 h post infection
revealed that HIV
SNAP and HIV
iSNAP virions were approximately
3-fold reduced in infectivity as compared to wt HIV. The subtle
increase in infectivity of HIV
iSNAP virions compared to HIV
SNAP
was found to be non-significant (p=0.65 as determined by
student’s t-test). Full infectivity on TZM-bl cells could however be
restored in mixed particles (Figure 2 A, gray bars). Since HIV
SNAP
was not impaired in virus-cell fusion, the decreased infectivity
indicates a defect at replication steps between cytoplasmatic entry
and viral gene expression. The late stages of virus replication were
analyzed by quantitating CA released into the supernatant relative
to the total amounts of Gag expressed in transfected cells (Figure 2
A, black bars). HIV
SNAP displayed no significant impairment in
bulk particle release (,20% decrease; p=0.097 as determined by
student’s t-test), which was not observed for HIV
iSNAP. Again, wt
properties were restored for HIV
SNAP upon co-transfection with
equimolar amounts of wt plasmid. In order to test the replication
capacity of the modified virus over multiple rounds of infection in
a T-cell line, particles generated by transfection of 293T cells using
pNLC4-3, pNLC
SNAP or pNLC
iSNAP, respectively, were used to
infect MT-4 cells and the amount of p24 CA released into the
tissue culture supernatant was monitored over 18 days post
infection (Figure 2 B). Replication kinetics of HIV
SNAP (filled
circles) were significantly delayed compared to wt HIV (open
Figure 1. Construction and characterization of an HIV derivative carrying a SNAP-tag within Gag. (A) Scheme of the HIV-1 gag open
reading frame indicating the snap-tag gene inserted between the MA and CA coding regions. Expanded regions display the junction between Gag
(bold) and SNAP-tag (grey boxes) amino acid sequences, separated by short linker sequences (italics) for HIV
SNAP and HIV
iSNAP constructs, respectively.
Arrowheads indicate cleavage sites for HIV-1 PR. (B) Immunoblot analysis of wt and modified virions. Particles released into the supernatant of 293T
cells transfected with the indicated proviral plasmids were purified by ultracentrifugation and subjected to immunoblot analysis using the indicated
antisera as described in methods. Positions of molecular mass standards are indicated at the left (in kDa). (C, D) Morphology of HIV and HIV
SNAP
virions. 293T cells transfected with pNLC4-3 (C) or pNLC
SNAP (D), respectively, were fixed at 24 h post transfection and embedded for EM analysis as
described in methods. Samples were analyzed by thin section electron microscopy.
doi:10.1371/journal.pone.0022007.g001
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days post infection. The introduction of an additional PR cleavage
site between the MA and SNAP moieties (HIV
iSNAP, triangles) did
not result in increased replication capacity under these conditions.
Since we did not observe a significant functional improvement of
HIV
iSNAP compared to HIV
SNAP in our assays, we focused on
HIV
SNAP for further characterization. The fact that the tag
remains associated with a viral protein even after proteolytic Gag
maturation is advantageous for many experimental setups, in
particular for analyses of HIV entry. In contrast to the analogous
construct HIV
eGFP, which did not replicate to detectable levels in
this cell line (filled squares), HIV
SNAP can be employed for the
study of virus-cell interactions in infected cells. Immunoblot
analyses of HIV
SNAP from the tissue culture supernatant at day 18
post infection (Figure 2 C) revealed only SNAP-tagged Gag
derivatives, indicating that the modified virus was stable over
several rounds of replication. These analyses were carried out
using the modified virus in the absence of SNAP substrates. In
order to test whether staining of Gag.SNAP affected virion
infectivity, purified HIV
SNAP virions treated with TMR-Star or
DMSO, respectively, were tested for infectivity by titration on
TZM-bl reporter cells as described in Methods S1. Staining
efficiency was analyzed in parallel by confocal microscopy of glass-
bound particles after counterstaining with antiserum raised against
HIV-1 CA. We found that particle preparations giving rise to
approximately 86% of double-labeled virions were only moder-
ately impaired in single-round infectivity as compared to the
DMSO control virus. Wild-type HIV-1 used as a negative control
was not stained by TMR-Star, but also displayed a similar
reduction in infectivity upon TMR-Star treatment, indicating that
the reduction was due to the treatment procedure rather than by
the presence of MA.SNAP -TMR-Star (Figure S1).
The suitability of the SNAP-tag label for specific detection of
intracellular HIV Gag was demonstrated by transfection of HeLa
cells with pCHIV
SNAP followed by staining of the transfected cells
with BG-TMR-Star (Figure 3 A). Co-transfection with the
previously characterized HIV derivative pCHIV
eGFP [4] which
allows the efficient detection of Gag using fluorescence microscopy
techniques was employed to investigate SNAP-tag staining
specificity and intracellular localization of Gag.SNAP. The
TMR-Star reactive Gag protein co-localized with Gag.eGFP in
virus expressing cells (Figure 3 A iii–v), indicating that Gag.SNAP
showed the correct intracellular localization and that Gag.SNAP
molecules arranged in Gag assemblies are accessible to the staining
Figure 2. Replication capacity of SNAP-tagged HIV derivatives. (A) Influence of the SNAP-tag insertion on distinct steps in HIV replication.
293T cells were transfected with pCHIV or pNLC4-3 (HIV), pCHIV
SNAP or pNLC
SNAP (HIV
SNAP), an eqimolar mixture of both plasmids (HIV
SNAP+HIV), or
with pNLC
iSNAP (HIV
iSNAP), respectively. Virions were harvested from the supernatant at 40 h post transfection. Values were normalized against the
mean of the respective control. White bars: Entry efficiency of pCHIV-derived particles, purified by ultracentrifugation through a sucrose cushion, was
measured on JC53 cells using the b-lactamase virion fusion assay as described in methods. Mean values and standard deviation from triplicate
samples are shown. n.d.=not determined. Light grey bars: Infectivity (in r.l.u. per ng CA) of pNLC4-3-derived particles was determined by titration of
viurs supernatants on TZM-bl reporter cells followed by analysis of luciferase activity as described in methods. Bars represent mean values and
standard deviation from 6 independent experiments. Black bars: For determination of release efficiency, the amount of p24 CA released into the
supernatant at 40 h post transfection was measured by quantitative immunoblot and divided by the sum of p24 in the supernatant and cell lysates.
Mean values and standard deviations from three independent experiments are shown. (B) Replication capacity of HIV derivatives. Equal amounts of
virus (0.5 ng p24 equivalent) produced from 293T cells transfected with pNLC4-3 (HIV; open circles), pNLC
SNAP (HIV
SNAP; filled circles), pNLC
iSNAP
(HIV
iSNAP; filled triangles), or pNLC
eGFP (HIV
eGFP; filled squares), respectively, were used to infect MT-4 cells. At the indicated time points post infection
the amount of CA released into the supernatant was determined by a quantitative dot blot analysis. Mean values and standard deviations from six
replicate infections are shown. (C) Retention of the SNAP-tag after several rounds of replication. Particles from tissue culture supernatants of infected
MT-4 cells at day 18 post transfection were analyzed by immunoblot using the indicated antisera. The position of molecular mass standards is
indicated at the left (in kDa).
doi:10.1371/journal.pone.0022007.g002
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HeLa cells. HeLa cells transfected with an equimolar mixture of pCHIV
eGFP and pCHIV
SNAP were labeled at 24 h post transfection using BG-TMR-Star as
described in methods; nuclei were stained with Hoechst 33258. The figure shows confocal images of a mid-section through a representative cell in
the green channel (i), red channel (ii), and as an overlay of green, red and blue channel (iii). Scale bars: 18 mm. Pearson’s coefficient for green and red
channels equals 0.754. The image in (iv) represents an enlarged section from (iii). (v) Fluorescence intensity profiles from the green and red channel
along the white line shown in (iv). (B, C) Intracellular detection of SNAP-tagged Gag protein in infected C8166 T-cells. C8166 cells were infected with
HIV (B) or HIV
SNAP (C), respectively, produced from transfected 293T cells. At 15 days post infection, cells were stained with BG-TMR-Star as well as by
immunofluorescence using an antiserum raised against HIV-1 CA; nuclei were stained with Hoechst 33258. The figure shows confocal images of mid-
sections for immunofluorescence (left panels), TMR-Star (middle panels) and an overlay of ap24, TMR-Star and Hoechst signals (right panels). Scale
bars: 8 mm. White asterisks: non-infected cell.
doi:10.1371/journal.pone.0022007.g003
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demonstrated by lack of signal in non transfected cells (Figure 3 A,
white asterisk). To further test the applicability of the tag in a more
physiological context, the T-cell line C8166 was infected with wt
HIV or HIV
SNAP, respectively, and stained with the SNAP-tag
reactive dye TMR-Star at 15 days post infection, i.e. after several
rounds of virus replication. To visualize infected cells, we performed
counterstaining with antiserum raised against HIV-1 CA. No
unspecific staining by TMR-Star was detected in cells infected with
wtHIV(Figure 3B).Incontrast,C8166cellsinfectedwithHIV
SNAP
virions displayed specific staining of Gag.SNAP by the fluorescent
SNAP substrate (Figure 3 C), while staining was absent in cells not
reactive to CA antiserum (Figure 3 C, white asterisk). The staining
pattern of TMR-Star differed somewhat from the pattern revealed
by immunolabeling, with the TMR-Star label displaying a higher
number of distinct punctuate signals at the plasma membrane of
virus producing cells (Figure 3 C, compare left and middle panel).
This is explained by the impaired antibody accessibility of epitopes
within CA in assembled viral structures, which is known to affect
detection of intracellular Gag assemblies by immunostaining and
immunoprecipitation approaches [35]. In contrast, assembled
Gag.SNAP appeared to be accessible for specific staining, yielding
a more faithful representation of intracellular Gag distribution. We
conclude that HIV
SNAP variants are suitable for live-cell imaging
analyses in infected T-cells.
The presence of the SNAP-tag, which can be labeled with a
variety of synthetic dyes, also makes the fusion protein amenable
to visualization by super-resolution fluorescence microscopy
techniques. Stimulated emission depletion (STED) microscopy
[36] or stochastic optical reconstruction microscopy (STORM)
[37] allow the localization of fluorescent molecules and the
analysis of labeled structures with a resolution well below the
diffraction limit [38], given that the protein of interest can be
specifically labeled with a suitable fluorophor. The genetically
encoded SNAP-tag in conjunction with appropriate dyes has
recently been demonstrated to be suitable for STED or STORM
analyses in living cells [39,40]. HIV
SNAP thus provides a basis for
the analysis of sub-viral structures in living cells. As a proof of
principle we applied direct STORM (dSTORM), a variation of
STORM relying on light-induced reversible photoswitching of
fluorophors [41], to visualize purified HIV
SNAP particles (Figure 4
A–C) as well as the membrane of HIV
SNAP expressing A3.01 T-
cells (Figure 4 D–F) in TIRF (total internal reflection fluores-
cence) mode. As shown in Figure 4 C, dSTORM images of
purified virions resolved individual punctuate signals with an
average full width half maximum of ,140 nm, which is in good
agreement with the average diameter of HI virions (145 nm)
determined by cryo-electron microscopy [42]. dSTORM images
of the plasma membrane of HIV
SNAP expressing T-cells revealed
individual budding sites with diameters around 150 nm; closely
Figure 4. Visualization of HIV
SNAP virions and budding sites by super-resolution TIRF microscopy. (A–C) High-resolution microscopy of
stained HIV
SNAP particles. HIV
SNAP particles were purified by ultracentrifugation from the supernatant of transfected 293T cells, bound to glass
coverslips and stained using SNAP-surface 647. Summed-molecule TIRF (A) and dSTORM (B) fluorescence images of the same region of interest are
shown. The white box indicates the particle magnified in (C). Scale bar: 1 mm. (C) Cross sectional profile derived from the dSTORM image of an
individual HIV particle. Scale bar: 200 nm. (D–F) HIV budding sites at the plasma membrane of an HIV
SNAP expressing T-cell. A3.01 cells were
nucleofected with pCHIV
SNAP, stained with SNAP-surface 647 and imaged as described in materials and methods. Summed-molecule TIRF (D) and
dSTORM (E) fluorescence images of the same cell are shown. (F) Magnified view of the boxed regions from the dSTORM image shown in (D). Scale
bar: 200 nm.
doi:10.1371/journal.pone.0022007.g004
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(Figure 4 E, F).
In conclusion, we consider the SNAP-tag based labeling strategy
presented here a useful expansion of the existing panel of
fluorescent HIV derivatives and a versatile tool to study different
aspects of the viral life cycle by microscopic techniques. It
combines the advantages of genetic labeling suitable for live-cell
analyses with the sensitivity and versatility of staining using
synthetic fluorescent dyes. The fact that SNAP-tagged molecules
can be either stained with various fluorescent dyes or quenched
with non-fluorescent substrate allows the application of sequential
labeling protocols for pulse-chase approaches [43] which may be
applied for the analysis of intracellular Gag trafficking from the site
of synthesis. Direct imaging studies of Gag trafficking have so far
been hampered by slow maturation kinetics of FPs which impair
visualization of newly synthesized Gag molecules. TC-tagged Gag
derivatives have been used to circumvent this problem, but studies
using this label yielded contradicting results, which might be
explained by non-specific intracellular staining with biarsenical
dyes [18,44]. Faster and more specific staining using HIV
SNAP
could surmount those shortcomings and thereby complement
biochemical analyses of Gag distribution. In addition, the
possibility to chose between differently colored dyes renders
HIV
SNAP a versatile tool for multi-color applications, e.g. for
investigation of dynamic interactions between HIV Gag and
individual host cell factors. Furthermore, the SNAP-tagged viral
protein can be labeled with synthetic dyes whose photochemical
properties are tailored to the requirements of super-resolution
microscopy techniques. In summary, the virus derivative described
here opens a variety of possibilities which will allow more detailed
investigation of HIV-cell interaction by modern microscopic
techniques.
Materials and Methods
Plasmids and cell lines
The snap-tag coding sequence was amplified by PCR from
pSS26m (Covalys) with primers introducing ClaI restriction sites at
both ends (GGCGCATCGATCCGCCCAGCCCAGGCTTG-
CC and CAGGGATCGATAGGCGGCATGGACAAAGACT-
GCGAA, respectively). The resulting fragment was subcloned into
pBSMAJ. ClaI harbouring a unique ClaI restriction site at position
1171 of the NL4-3 sequence [31] resulting in pBSMAJ
SNAP.A
BssHII-SphI fragment comprising the modified MA sequence was
then transferred into the pCHIV and pNLC4-3 [45] context to
obtain pCHIV
SNAP and pNLC
SNAP, respectively. For construction
of pNLC
iSNAP, the snap-tag coding sequence was amplified by PCR
using forward and reverse primers introducing a MluI and an XbaI
restriction site, respectively (TGTACAAACGCGTATGGA-
CAAAGACTGC and TTTTGGCTTCTAGAGCCCAGCC-
CAGGC). The resulting fragment was inserted into pNLC.iGFP,
a derivative of pNLC4-3 [45] where an additional HIV protease
cleavage site followed by GFP had been introduced C-terminally of
MA by insertion of the BssHII-SphI fragment from plasmid HIV
Gag-iGFP [33], to obtain pNLC
iSNAP.
293T [46], HeLa [47], JC53 [48] and TZM-bl [49] cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM Gluta-
MAX; Invitrogen) supplemented with 100 U/ml penicillin,
100 mg/ml streptomycin and 10% FCS at 37uC, 5% CO2.
C8166 [50], MT4 [51] and A3.01 [52] cells were kept in
RPMI1640 GlutaMAX
TM supplemented with 100 U/ml penicil-
lin, 100 mg/ml streptomycin and 10% FCS. Transfections were
carried out using polyethyleneimine (PEI) according to standard
procedures (293T cells) or FuGeneHD (Roche) according to the
manufacturer’s conditions. A3.01 T cells were electroporated in a
0.4 cm cuvette (Invitrogen) at voltage 300, capacity of 950 mFi na
volume of 500 ml of serum-free medium using the Gene Pulser
Xcell System (Bio Rad).
Particle preparation and immunoblot characterization
293T cells were transfected with the proviral plasmids using
PEI. At 44 h post transfection, cells were harvested and lysed in
SDS sample buffer. Tissue culture supernatants were precleared
by filtration through a 0.45 mM filter and virions were purified by
ultracentrifugation through a 20% (w/w) sucrose cushion. Proteins
from cell lysates and pelleted particles were separated by SDS-
PAGE (acrylamide:bisacrylamide 200:1, 17.5% acrylamide) and
transferred to a nitrocellulose membrane by semi-dry blotting.
Membranes were probed with the indicated primary antisera and
bound antibodies were detected by quantitative immunoblot using
a LiCor Odyssey system, as well as reagents, protocols and
software provided by the manufacturer.
Analysis of virion infectivity
TZM-bl indicator cells seeded in 96-well plates at 8610
3 cells/
well were infected one day after seeding using serial dilutions of
filtered tissue culture supernatant form 293T cells transfected with
pNLC-4.3, pNLC
SNAP or pNLC
iSNAP, respectively. At 48 h post
infection, luciferase activity as a measure for infected cells was
determined using the SteadyGlo Assay System (Promega)
according to the manufacturer’s instructions.
b-Lactamase Virion Fusion Assay
Entry efficiency was determined by a standard HIV fusion assay
[34]. Briefly, viral particles were prepared from 293T cells co-
transfected with the indicated HIV proviral derivative and
pMM310 [53] (plasmid ratio 15:1 mg). Particle concentration
was determined by quantitative immunoblot using antiserum
raised against HIV-1 CA. Serial dilutions of virus were used to
infect JC53 cells seeded in 96-wells one day prior to infection.
Following incubation at 37uC for 6 h, cells were washed with
CO2-independent DMEM (Invitrogen) and incubated for 12 h at
room temperature using CCF2-AM (GeneBLAZER, Invitrogen
Ltd., Paisley, UK) according to the manufacturer’s protocol. Cells
were fixed with 3% PFA/PBS and fluorescence intensities at Em
447 nm and 520 nm (Ex: 409 nm) were determined in a multi-
well fluorimeter (Tecan SAFIRE). The ratio of fluorescence
emission at 520 nm over emission at 447 nm was calculated and
normalized to the corresponding ratio obtained for uninfected cells
to yield relative entry efficiencies.
Replication kinetics of HIV-1 derivatives
HIV, HIV
SNAP and HIV
iSNAP were produced by transfection of
293T cells with the plasmids pNLC4-3, pNLC
SNAP and
pNLC
iSNAP, respectively. The amount of p24 CA in the
supernatant was determined by quantitative immunoblot and
supernatant corresponding to 0.5 ng of p24 CA was used to infect
1610
5 MT-4 cells. Samples of tissue culture supernatant were
collected every 2 days the amount of p24 in the supernatant was
determined by a quantitative Dot Blot procedure. Briefly, 80 mlo f
supernatant were spotted onto a nitrocellulose membrane using a
MinifoldH I device (Whatman). A serial dilution of purified,
recombinant HIV-1 CA [54] was used as a standard. The
membrane was dried, blocked with 5% skimmed milk powder in
TBS/0,5% Tween 20 and probed with rabbit polyclonal
antiserum raised against HIV-1 CA. Signals were detected by
quantitative immunoblot using a LiCor Odyssey system as well as
A SNAP-Tagged Derivative of HIV-1
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Intracellular staining of Gag.SNAP
Hela cells seeded on coverslips 24 h prior to the experiment
were transfected with FuGene6 (Roche) and incubated at 37uC for
24 h. For SNAP-labelling cells were incubated with 1 mM SNAP-
cell TMR-Star (New England Biolabs) in DMEM for 15 min at
37uC, washed and incubated in fresh DMEM for 45 min at 37uC
to allow diffusion of excess substrate. Cells were then fixed with
3% paraformaldehyde (PFA), counterstained with Hoechst 33258
and embedded in Mowiol. C8166 cells infected with HIV
SNAP or
HIV were subjected to a modified protocol in solution using the
same conditions as above. Between the different steps, cells were
pelleted at 4’000 rpm for 4 min. Following fixation with 3% PFA
cells were adhered to fibronectin coated cover slips and
permeabilized by incubation with 0.1% TritonX-100/PBS and
subjected to intracellular staining using rabbit polyclonal serum
raised against HIV-1 CA and Alexa488 goat anti rabbit antibody
(Invitrogen). Counterstaining of nuclei was performed using
Hoechst 33258 in the secondary antibody solution.
Electron microscopic analysis of cell samples
293T cells were transfected with pNLC4-3 or pNLC
SNAP,
respectively, using FuGene HD (Roche Diagnostics GmbH,
Mannheim, Germany). At 24 h post transfection the cells were
fixed and processed for resin-embedding as described previously
[55]. Sections were examined with a Zeiss EM10 TEM and
images taken using a Gatan MultiScan
TM camera and Digital
Micrograph
TM software.
dSTORM analysis of virions and virus producing cells
Particles were purified from the supernatant of 293T cells
transfected with an equimolar mixture of pCHIV and pCHIV
S-
NAP by ultracentrifugation through a 20% sucrose cushion.
Particles were adhered to fibronectin coated glass coverslips and
fixed with 3% paraformaldehyde in PBS.Viruses were permeabi-
lized with 0.01% Triton X-100 for 10 seconds, blocked with 2%
bovine serum albumin (BSA) in PBS for 30 min and stained with
5 mM SNAP-surface 647 (NEB) according to the manufacturer’s
instructions. For the analysis of HIVexpressing cells, 5610
5 A3.01
cells were electroporated with 10 mg of pCHIV
SNAP. At 24 h post-
transfection, cells were transferred to LabTek 8-well chambered
coverglasses and fixed with 3% paraformaldehyde in PBS for
15 min. The fixed cells were washed and permeabilized using
0.1% Triton X-100 for 10 min. After blocking with 2% BSA
solution for 30 min, cells were stained with 5 mM SNAP-surface
647 according to manufacturer’s instructions. dSTORM images
were recorded on a custom-built microscope using experimental
protocols that were described earlier [41]. Briefly, a multi-line laser
(Innova 70C, Coherent, USA) was coupled into an inverted
microscope (IX71, Olympus, Japan), and the fluorescence signal
was detected using an electron-multiplying charge-coupled device
(EMCCD) (Ixon, Andor, Ireland) and appropriate filters and
dichroics (AHF, Germany). Photoswitching of Alexa Fluor 647
was realized in oxygen-free aqueous buffer with 100 mM
mercaptoethylamine added and using two irradiation wavelengths,
514 nm (0.1–1 kW/cm
2) for activation and 647 nm (1–5 kW/
cm
2) for read-out. Image reconstruction was performed using the
rapidSTORM software package [56]. dSTORM images shown
consist of 8000 individual superimposed frames. Summed-
molecule TIRF images were reconstructed by summing up
single-molecule fluorescence intensities from the complete data set.
Supporting Information
Figure S1 Infectivity of HIV
SNAP virions after TMR-Star
staining. HIV and HIV
SNAP particles were purified by
ultracentrifugation from the supernatant of 293T cells transfected
with pNLC4-3 or pNLC
SNAP, respectively, and incubated with
1.2 mM TMR-Star or a solvent control (DMSO) for 1 h at room
temperature. Unbound dye was removed by gel filtration. (A)
Western-blot analysis of HIV and HIV
SNAP particles stained with
TMR-Star or DMSO using the indicated antisera. The position of
molecular mass standards is indicated at the left (in kDa). (B)
Staining specificity and efficiency was determined by confocal
microscopy of particles adhered to fibronectin coated glass
coverslips. TMR-Star stained particles were fixed with 3% PFA,
permeabilized with 0.01% Triton X-100 and blocked with 2%
bovine serum albumin in PBS. HIV-1 CA was detected by
immunostaining using a polyclonal sheep anti CA serum and
Alexa488 secondary antibody. Representative confocal microsco-
py images and percentage of signals in the indicated channels are
depicted. (C) Infectivity of particles as determined by titration of
stained (black bars) or solvent treated (white bars) particles on
TZM-bl indicator cells as described in Methods. Values were
normalized for the amount of input virus as determined by
quantitative immunoblot analysis compared to a purified CA
protein standard. Mean values and standard deviation of triplicate
titrations are shown. RLU, relative light units.
(TIF)
Methods S1 Infectivity of HIV
SNAP particles after stain-
ing.
(DOC)
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